The next board meeting for 4D Molecular Therapeutics Inc is on 08 May 2026 for the purpose of 4D Molecular Therapeutics Inc First Quarter Earnings Results for 2026See details
4D Molecular Therapeutics Inc has a share price target of US$ 29, revenue growth forecast of -88.4%, and profit growth estimate of -77.6% for FY26, based on top 10 analyst calls.